Oruka Therapeutics, Inc. (ORKA)

SEC filing

Oruka Therapeutics, Inc.

ORKA · CIK 907654

4 · Oct 2, 2026 · Director, Chief Executive Officer Klein Lawrence Otto sold 25K shares at $83.62/share ($2.1M); exercised options for 50K shares

Director, Chief Executive Officer Klein Lawrence Otto sold 25K shares at $83.62/share ($2.1M); exercised options for 50K shares

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov